|
Knowledge Base
Related To This Page: |
Anti-Aging LED Light Therapy
Anti-Aging Techniques:
Anti-Aging Nonablative Light Therapy: |
Search Our Web Site |
|||||||||||||||||||||||||||||||||||
| >> anti-aging treatment >> anti-aging techniques >> Nonablative Anti-Aging Light Therapy >> Anti-Aging LED Light Therapy | |||||||||||||||||||||||||||||||||||||
|
|
Infrared/Red LED Light Therapy Infrared/Red LED (light emitting diode) light therapy is a FDA approved, affordable, noninvasive, safe and natural skin rejuvenation techniques without surgery, lasers, peels or injections. Anti-aging LED light therapy was initially developed by NASA research. The effects of infrared LED light therapy on the skin and body have been reported in over 2000 scientific reports and documents. Red and infrared light emitting diodes (LED's) are convenient sources of intense light at wavelengths. It was found that optimal LED wavelengths for tissue penetration are 680, 730 and 880 nm. All studies to this date show that LED pulsed light treatment is as effective as or more effective than laser treatment. LED light therapy reduces lines, folds and wrinkles, increase circulation, moisture and radiance, accelerates skin repair, stimulates fibroblast and collagen, elastin production, improves elasticity and skin texture. Lymph vessels open and drain more efficiently to remove toxic waste. LED light therapy also treats hyperpigmentation — age spots, freckles, uneven pigmentation due to sun exposure, etc: Most cases of skin hyperpigmentation even out over time from the use of infrared LED light therapy. In addition, LED light therapy can treat acne, shrink pore size, diminish the redness of rosacea . There is no "down time" after treatment. Cosmetic use of this therapy has produced no reported discomfort or side effects. It is safe for any age, color, and skin type. Visit our "Nonablative anti-aging light therapy" for an overview and comparison of different nonablative light treatment (laser and fractional laser, IPL, LED). Visit our Knowledge Base -- "Anti-Aging Techniques Knowledge Base" for background knowledge about nonablative light treatment methods. Home Use LED Therapy DeviceTherapy can be administered in the home, with units retailing between $500- $2,500. There is a variation in the lights used, with some having smaller, weaker 3 - 5 mm lights, whilst other [surprisingly cheaper] units boasting most powerful 10 mm lights known as ‘Super Bright’ LED. Home use LED therapy device is now available. DPL System™ (Deep Penetrating Light Therapy DPL™ System ) is an affordable, portable home use system to treat wrinkles, and other signs of aging skin. Some other system are available on the market.
RejuvaWandRejuvaWand, a LED anti-aging device for home use, was launched by Light Dimensions in 2007. It combines RejuvaWand combines relaxing massage Rejuva™Vibe with red and infrared laser light to invigorate the body’s own restorative process. Light from the RejuvaWand permeates the top layers of the skin, stimulating your cells to produce more energy ATP. Increased ATP promotes anti aging by stimulating collagen growth, improving skin structure, and reducing wrinkles. The wand works in tandem with Rejuva Gel. Anti-Aging skin Care Rejuva Moist, Rejuva Cleanse, and Rejuva Toner, come with the package are used to enhance the effect. The procedure is safe, affordable with no side effect at all, and only take 4 minutes to treat each area (forehead, eye corner, laugh line). Read more on Rejuvawand. .. Photo Therapeutics Enters Consumer Market with N.V. Perricone MDarticle source: (Business Wire, Sept 19, 2008)CARLSBAD, Calif. -- Photo Therapeutics (PTL), a leader in the development of proprietary therapeutic LED technology for the physician dermatology market, announced today with PhotoMedex, Inc. (NASDAQ: PHMD) that, thanks to N.V. Perricone MD., Ltd., its Omnilux LED-based technology has made its debut to the consumer market. N.V. Perricone M.D. launches LIGHT Renewal[TM] N.V. Perricone M.D. Cosmeceuticals[R] has introduced LIGHT Renewal[TM] treatment to the prestige beauty market. This treatment was developed in conjunction with Photo Therapeutics and combines PTL's Omnilux technology with Dr. Perricone's Nourishing Milky Cleanser and Serum prep to ensure the skin is properly prepared and ready to receive the benefits of this light technology in a dermatological-grade unit that softens fine lines and wrinkles, while improving the appearance of the skin's tone, texture and firmness. Two clinical trials - one lasting 12 weeks, one lasting nine weeks - showed effectiveness in rejuvenating skin and reducing fine lines and peri-orbital wrinkles. "We are excited to be joining forces with Perricone MD Cosmeceuticals, one of the most reputable and fastest growing skin care lines in the world," said Sue D'Arcy, Chief Executive Officer of Photo Therapeutics. "We believe there is a dynamic synergy between our LED Light Therapy technology and Perricone MD Cosmeceuticals that will deliver exceptional results." Perricone skincare products are sold in many high-end skincare outlets such as Sephora, Nordstrom and Bloomingdale's. Additionally, Photo Therapeutics is taking final steps to introduce its Omnilux New-U[TM] to the home-use market. This FDA-cleared, hand-held device is being made available in a major retailer's outlets across the country. Photo Therapeutics has announced its intent to be acquired by PhotoMedex, Inc., leaders in medical laser treatments for psoriasis and other skin diseases and marketers of skincare products to dermatologists. This union is expected to spur further investment in the research, development and marketing of Photo Therapeutics' LED and light-based therapies under PhotoMedex to complement therapies in the medical, beauty and cosmetic fields. Ms. D'Arcy stated: "It makes perfect sense to team up with PhotoMedex. Working together, we can answer the demand in this emerging market." About the Proposed Photo Therapeutics Acquisition On August 4, 2008 Photo Therapeutics and PhotoMedex signed a definitive agreement for PhotoMedex to acquire Photo Therapeutics. The proposed acquisition is expected to close in the fourth quarter of 2008 and is expected to be funded through an investment of convertible debt provided by a third-party investment fund. PhotoMedex will seek approval from its stockholders for the investment; the shareholders of Photo Therapeutics have already ratified the definitive agreement and the terms proposed for financing the acquisition. About Photo Therapeutics Photo Therapeutics is a developer and provider of non-laser light devices and associated skin care products for the treatment of a range of clinical and aesthetic dermatological conditions. The company operates out of three primary business segments: Professional Devices, Home Use Devices and Skin Care Consumables. The company has a large professional installed base in physician offices, spas and salons. Photo Therapeutics' Omnilux and Lumiere product platforms have generated significant brand equity among professionals and end users given their proven efficacy, ease of use and noninvasive, pain-free regimes. The company's systems treat a wide range of dermatological conditions including acne, photodamage, skin rejuvenation, psoriasis, post-surgery wound healing and non-melanoma skin cancer. LED technology is based on photo biomodulation and dynamics rather than photo-thermolysis. Photo Therapeutics has recently developed the Omnilux Clear-U and Omnilux New-U, two OTC consumer products addressing the acne and skin rejuvenation markets. The company's home-use products are designed to deliver the same clinical results as their well established professional products. To augment the effects of the Omnilux OTC product line, Photo Therapeutics provides a diverse line of photoceuticals, which generate incremental recurring revenue per end user. Photo Therapeutics' LED technology is protected by 18 patents and 20 applications, which the company believes will restrict other parties from developing similar products. About PhotoMedex PhotoMedex offers a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics and other surgical specialties. PhotoMedex is a leader in the development, manufacturing and marketing of medical laser products and services. PhotoMedex also develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including a long-term worldwide license agreement with Neutrogena(R), a Johnson & Johnson company. ProCyte brands include Neova(R), Ti-Silc(R), VitalCopper(R), Simple Solutions(R) and AquaSante(R). Related Pages:
|